New drug targets and small molecules for promoting cardiac regeneration

Bidragets beskrivning

Currently, there is no effective drug treatment for post-infarction heart failure, which is a major public health issue and a huge economic burden. The adult human heart cannot repair the tissue injury caused by myocardial infarction, and the loss of cardiomyocytes leads to the development of heart failure. Remarkably, zebrafish and neonatal rodents can regenerate their hearts. This involves generation of new blood vessels and proliferation of existing cardiomyocytes, but the mechanisms regulating these phenomena are not fully understood. By elucidating endogenous mechanisms of cardiac regeneration, this work aims to identify new drug targets for cardiac regeneration-inducing therapies and develop small molecule compounds with potential cardiac regeneration-enhancing activity.
Visa mer

Startår

2019

Slutår

2024

Beviljade finansiering

Virpi Talman Orcid -palvelun logo
438 874 €

Andra beslut

353109
Akademiforskarens forskningskostnader(2022)
200 000 €
328909
Akademiforskarens forskningskostnader(2019)
300 000 €

Finansiär

Finlands Akademi

Typ av finansiering

Akademiforskare

Övriga uppgifter

Finansieringsbeslutets nummer

321564

Vetenskapsområden

Farmaci

Forskningsområden

Farmasia

Identifierade teman

cardiovascular diseases